Menopur And Rekovelle Combination Study (MARCS)
An Exploratory Study to Evaluate a Mixed Protocol of Menopur (Highly Purified Human Menopausal Gonadotropin) and REKOVELLE (Follitropin Delta) for Controlled Ovarian Stimulation in IVF (in Vitro Fertilization)
Sponsor: Create Fertility Center
Listed as NCT03483545, this NA trial focuses on Fertility Disorders and remains completed. Sponsored by Create Fertility Center, it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Oct 2021 [monthly]
Completed NA
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 5 earlier versions
-
Feb 2019 — Sep 2019 [monthly]
Recruiting NA
-
Nov 2018 — Feb 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Aug 2018 — Nov 2018 [monthly]
Not Yet Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Create Fertility Center
- Dr François Bissonnette
- Hannam Fertility Centre
- Olive Fertility Centre
For direct contact, visit the study record on ClinicalTrials.gov .